External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Gastroenterology ISDE 2026
Roche and Genentech at

ISDE 2026

September 16 - September 18
Kyoto, Japan
isde.net
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:45 AM
Duration 12mins Kyoto, Japan
Updated results from the phase III SKYSCRAPER 07 study of atezolizumab with or without tiragolumab vs placebo in patients with unresectable esophageal squamous cell carcinoma that has not progressed following definitive concurrent chemoradiotherapy
Kei Muro
Oncology | Esophageal Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.